» Articles » PMID: 12519076

Converging Signals Synergistically Activate the LAMC2 Promoter and Lead to Accumulation of the Laminin Gamma 2 Chain in Human Colon Carcinoma Cells

Overview
Journal Biochem J
Specialty Biochemistry
Date 2003 Jan 10
PMID 12519076
Citations 15
Authors
Affiliations
Soon will be listed here.
Abstract

The trimeric extracellular matrix molecule laminin-5 and its constituent chains (alpha 3, beta 3, gamma 2) are normally not detectable intracellularly in intestinal epithelial cells but the laminin gamma 2 chain can be detected in cancer cells at the invasive front of a subset of colon carcinomas. These cells are subjected to cytokines such as transforming growth factor beta 1 (TGF-beta 1) and hepatocyte growth factor (HGF), produced by the tumour cells or by the surrounding stromal cells. The purpose of the present work was to investigate whether TGF-beta 1 and HGF, known to stimulate the LAMC2 gene encoding the laminin gamma 2 chain, might synergize to activate the LAMC2 promoter, and to identify the promoter elements involved. We find evidence for synergy between TGF-beta and HGF with respect to laminin gamma 2 chain expression and promoter activation and demonstrate that this requires the 5' activator protein-1 (AP-1) element of the promoter and an additional upstream element which is also responsive to co-expression of the Smad3 protein from the TGF-beta signalling pathway. The transcripts encoding the other laminin-5 chains are not synergistically activated by HGF and TGF-beta. Thus the synergistic activation of the LAMC2 gene is mediated via different cis-elements and results in an overproduction of the laminin gamma 2 chain relative to the other laminin-5 constituent chains. This difference may explain why laminin gamma 2 chains accumulate in the cells at the invasive front of colon carcinomas.

Citing Articles

An AI-assisted morphoproteomic approach is a supportive tool in esophagitis-related precision medicine.

Mattern S, Hollfoth V, Bag E, Ali A, Riemenschneider P, Jarboui M EMBO Mol Med. 2025; 17(3):441-468.

PMID: 39901020 PMC: 11903792. DOI: 10.1038/s44321-025-00194-7.


LncRNAs-Regulated High Expression of LAMC2 Reveals a Prognostic and Immunological Value in Pancreatic Adenocarcinoma.

Liu J, Wang M, Wang M, Wang F, Zhang B Biochem Genet. 2023; 62(1):485-503.

PMID: 37382751 DOI: 10.1007/s10528-023-10435-4.


Anti-Laminin 332-Type Mucous Membrane Pemphigoid.

Shi L, Li X, Qian H Biomolecules. 2022; 12(10).

PMID: 36291670 PMC: 9599625. DOI: 10.3390/biom12101461.


TROP2 Represents a Negative Prognostic Factor in Colorectal Adenocarcinoma and Its Expression Is Associated with Features of Epithelial-Mesenchymal Transition and Invasiveness.

Svec J, Stastna M, Janeckova L, Hrckulak D, Vojtechova M, Onhajzer J Cancers (Basel). 2022; 14(17).

PMID: 36077674 PMC: 9454662. DOI: 10.3390/cancers14174137.


LAMB3 promotes tumour progression through the AKT-FOXO3/4 axis and is transcriptionally regulated by the BRD2/acetylated ELK4 complex in colorectal cancer.

Zhu Z, Song J, Guo Y, Huang Z, Chen X, Dang X Oncogene. 2020; 39(24):4666-4680.

PMID: 32398865 DOI: 10.1038/s41388-020-1321-5.


References
1.
Simon-Assmann P, Kedinger M, DE ARCANGELIS A, Rousseau V, Simo P . Extracellular matrix components in intestinal development. Experientia. 1995; 51(9-10):883-900. DOI: 10.1007/BF01921739. View

2.
Kristensen P, Eriksen J, Blasi F, Dano K . Two alternatively spliced mouse urokinase receptor mRNAs with different histological localization in the gastrointestinal tract. J Cell Biol. 1991; 115(6):1763-71. PMC: 2289218. DOI: 10.1083/jcb.115.6.1763. View

3.
Birchmeier W, Birchmeier C . Epithelial-mesenchymal transitions in development and tumor progression. EXS. 1995; 74:1-15. DOI: 10.1007/978-3-0348-9070-0_1. View

4.
Lee J, See R, Deng T, Shi Y . Adenovirus E1A downregulates cJun- and JunB-mediated transcription by targeting their coactivator p300. Mol Cell Biol. 1996; 16(8):4312-26. PMC: 231430. DOI: 10.1128/MCB.16.8.4312. View

5.
Morin P, Vogelstein B, Kinzler K . Apoptosis and APC in colorectal tumorigenesis. Proc Natl Acad Sci U S A. 1996; 93(15):7950-4. PMC: 38855. DOI: 10.1073/pnas.93.15.7950. View